FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. Common Stock (FBLG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FBLG · as of Jun 9, 2026
Key Statistics
Explore FibroBiologics, Inc. Common Stock Data
fblg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
The FBLG analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $180.00, representing +17721.78% upside from the current price of $1.01.
Competitors & Peers
fblg competitorsFBLG
ADTX
AIMD
APLM
ATHA
CTXRStock Performance
Full HistoryAbout FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. Common Stock FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline include…
what is fibrobiologics, inc. common stock · fblg stock overview · fibrobiologics, inc. common stock company profile · who is fibrobiologics, inc. common stock ceo · fblg NASDAQ · fibrobiologics, inc. common stock headquarters · fibrobiologics, inc. common stock business segments
About Stock Overview & Key Data
FibroBiologics, Inc. Common Stock (FBLG) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 1, 2024. As of the latest trading session, FBLG stock price is $1.01, with a market capitalization of $2.1M. The stock has returned -94.66% over the past 12 months and -77.56% year-to-date.
According to 4 Wall Street analysts, the consensus rating for FibroBiologics, Inc. Common Stock stock is Buy, with an average 12-month price target of $180.00. In fiscal year 2025, FibroBiologics, Inc. Common Stock reported revenue of — and net income of -$18.6M. For detailed data — including FibroBiologics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, FibroBiologics, Inc. Common Stock (FBLG) stock price is $1.01. The stock is traded on NASDAQ under the ticker symbol FBLG. The 52-week range is $0.95 – $19.80.